49.79
Ptc Therapeutics Inc Stock (PTCT) Latest News
Rett Syndrome Market Growth Projections 2024-2034: - openPR
PTC Therapeutics' SWOT analysis: stock poised for growth amid regulatory challenges - MSN
Cantor Fitzgerald Issues Negative Estimate for PTCT Earnings - MarketBeat
Duchenne Muscular Dystrophy Market Report 2034: Epidemiology - openPR
PTC Therapeutics price target raised to $113 from $76 at Cantor Fitzgerald - Yahoo Finance
PTC Therapeutics (PTCT) Moves 9.0% Higher: Will This Strength Last? - Yahoo Finance
PTC Therapeutics rises 9% after Cantor raises price target to Street high - MSN
Why PTC Therapeutics (PTCT) Stock Is Rallying Today - Insider Monkey
PTC Therapeutics (NASDAQ:PTCT) Trading Up 6.1% on Analyst Upgrade - MarketBeat
PTC Therapeutics (NASDAQ:PTCT) Price Target Raised to $113.00 - MarketBeat
Cantor Fitzgerald lifts PTC Therapeutics stock target to $113 By Investing.com - Investing.com Australia
Cantor Fitzgerald lifts PTC Therapeutics stock target to $113 - MSN
Cowen raises PTC Therapeutics stock price target to $50 - MSN
Cowen raises PTC Therapeutics stock price target to $50 By Investing.com - Investing.com Nigeria
(PTCT) Technical Data - Stock Traders Daily
PTC Therapeutics, Inc. (NASDAQ:PTCT) Receives $55.00 Consensus PT from Analysts - Defense World
PTCT SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into PTC Therapeutics, Inc and Encourages Investors to Contact the Firm Today! - ACCESS Newswire
PTC Therapeutics, Inc. (NASDAQ:PTCT) Receives Average Recommendation of "Hold" from Brokerages - MarketBeat
Analysts Issue Forecasts for PTCT FY2025 Earnings - Defense World
What is Leerink Partnrs’ Forecast for PTCT FY2024 Earnings? - Defense World
What is Leerink Partnrs' Estimate for PTCT FY2024 Earnings? - MarketBeat
PTC Therapeutics Stock Soars on Novartis Licensing Agreement - MSN
Assenagon Asset Management S.A. Sells 52,794 Shares of PTC Therapeutics, Inc. (NASDAQ:PTCT) - MarketBeat
FY2024 EPS Estimates for PTCT Lifted by Cantor Fitzgerald - Defense World
William Blair Lifts Earnings Estimates for PTC Therapeutics - Defense World
Gastroparesis Pipeline Trends 2024: Clinical Trials, Therapeutic Innovations, and FDA Approvals | CinDome Pharma, Inc., Evoke Pharma, Vanda Pharma, Ironwood Pharma, Takeda, Neurogastrx, Inc, PTC Thera - The Globe and Mail
William Blair Boosts Earnings Estimates for PTC Therapeutics - MarketBeat
PTC Therapeutics' SWOT analysis: rare disease biotech stock faces pivotal year - Investing.com Australia
Cantor Fitzgerald Issues Pessimistic Forecast for PTC Therapeutics (NASDAQ:PTCT) Stock Price - MarketBeat
PTC Therapeutics sees several potential catalysts in 2025 - MSN
Orsini the Exclusive Specialty Pharmacy Provider for Gene Therapy KEBILIDI™ (eladocagene exuparvovec-tneq) - Yahoo Finance
Muscular Dystrophy Treatment Market Next Big Thing Forecast By 2031 | Santhera Pharmaceuticals, PTC Therapeutics - openPR
PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Yahoo Finance
PTC Therapeutics Surpasses Revenue Guidance for 2024 - TipRanks
PTC Therapeutics reports $814 million in 2024 revenue, surpassing goals - Investing.com
PTC Therapeutics reports $814 million in 2024 revenue, surpassing goals By Investing.com - Investing.com South Africa
PTC Therapeutics Provides Update on Commercial Performance and R&D Pipeline at 43rd Annual J.P. Morgan Healthcare Conference - Longview News-Journal
Ptc Therapeutics' chief accounting officer sells $132,492 in stock - Investing.com India
Ptc Therapeutics' chief accounting officer sells $132,492 in stock By Investing.com - Investing.com South Africa
PTC Therapeutics CEO Eric Pauwels sells $167,550 in stock By Investing.com - Investing.com South Africa
Ptc Therapeutics exec VP sells shares worth $158,870 By Investing.com - Investing.com Australia
Ptc Therapeutics CEO Matthew Klein sells $204,007 in stock - Investing.com India
Ptc Therapeutics CEO Matthew Klein sells $204,007 in stock By Investing.com - Investing.com Australia
Ptc Therapeutics exec VP sells shares worth $158,870 - Investing.com India
Ptc therapeutics' EVP sells $90,036 in stock By Investing.com - Investing.com Australia
PTC Therapeutics, Inc. (NASDAQ:PTCT) EVP Lee Scott Golden Sells 810 Shares - MarketBeat
Insider Selling: PTC Therapeutics, Inc. (NASDAQ:PTCT) VP Sells 1,543 Shares of Stock - MarketBeat
PTC Therapeutics, Inc. (NASDAQ:PTCT) CAO Christine Marie Utter Sells 1,291 Shares - MarketBeat
PTC Therapeutics, Inc. (NASDAQ:PTCT) Insider Neil Gregory Almstead Sells 1,265 Shares - MarketBeat
Ptc therapeutics’ EVP sells $90,036 in stock By Investing.com - Investing.com Nigeria
PTC Therapeutics CEO Eric Pauwels sells $167,550 in stock - Investing.com
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):